Search research articles
Contact Us
Filters
Showing results (91-100 of 143) with videos related to
Page
of 15
Sort By:
Journal of Neuropathology and Experimental Neurology
|
June 25, 2022
Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 10, 2024
Conjugal Synucleinopathies: A Clinicopathologic Study
Charles H Adler, Matthew Halverson, Nan Zhang, et al.
Acta Neuropathologica
|
June 23, 2025
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants
Andrea Mastrangelo, Serena Caldera, Sophie E Mastenbroek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 6, 2024
Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core dataset
James E Galvin, Jeffrey L Cummings, Mihaela Levitchi Benea, et al.
Journal of Neuropathology and Experimental Neurology
|
February 22, 2022
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathology
Cecilia Tremblay, Parichita Choudhury, Erika Driver-Dunckley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 22, 2026
Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup
Ellis S van Etten, Simin Mahinrad, Joshua D Grill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement
Dorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Neurobiology of Disease
|
April 25, 2024
RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction
Cécilia Tremblay, Sidra Aslam, Jessica E Walker, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
July 18, 2008
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals
Bradford C Dickerson, Akram Bakkour, David H Salat, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 143) with videos related to
Sort By:
Page
of 15
Journal of Neuropathology and Experimental Neurology
|
June 25, 2022
Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 10, 2024
Conjugal Synucleinopathies: A Clinicopathologic Study
Charles H Adler, Matthew Halverson, Nan Zhang, et al.
Acta Neuropathologica
|
June 23, 2025
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants
Andrea Mastrangelo, Serena Caldera, Sophie E Mastenbroek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 6, 2024
Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core dataset
James E Galvin, Jeffrey L Cummings, Mihaela Levitchi Benea, et al.
Journal of Neuropathology and Experimental Neurology
|
February 22, 2022
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
Cécilia Tremblay, Geidy E Serrano, Anthony J Intorcia, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathology
Cecilia Tremblay, Parichita Choudhury, Erika Driver-Dunckley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 22, 2026
Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup
Ellis S van Etten, Simin Mahinrad, Joshua D Grill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement
Dorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Neurobiology of Disease
|
April 25, 2024
RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction
Cécilia Tremblay, Sidra Aslam, Jessica E Walker, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
July 18, 2008
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals
Bradford C Dickerson, Akram Bakkour, David H Salat, et al.
Page
of 15